Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIT | P10721 | 8/20 | 1.00 |
| ▸ | ABL1 | P00519 | 8/20 | 0.73 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.71 |
| ▸ | KDR | P35968 | 2/20 | 0.71 |
| ▸ | BRAF | P15056 | 2/20 | 0.71 |
| ▸ | CSF1R | P07333 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4103102 | 1.00 | KIT (1.00) | KITABL1FGFR1KDRBRAF | |
| SCHEMBL17936186 | 0.96 | KIT (0.93) | KITABL1FGFR1KDRBRAF | |
| SCHEMBL30080773 | 0.96 | KIT (0.93) | KITABL1FGFR1KDRBRAF | |
| SCHEMBL16755299 | 0.93 | KIT (0.87) | KITABL1FGFR1KDRBRAF | |
| SCHEMBL28054397 | 0.93 | KIT (0.86) | KITABL1FGFR1KDRCSF1R | |
| SCHEMBL16250591 | 0.92 | KIT (0.85) | KITABL1FGFR1KDRBRAF | |
| SCHEMBL24503732 | 0.92 | KIT (0.85) | KITABL1FGFR1KDRBRAF | |
| SCHEMBL18323290 | 0.92 | KIT (0.85) | KITABL1FGFR1KDRBRAF | |
| SCHEMBL4095171 | 0.91 | KIT (0.84) | KITABL1FGFR1KDRBRAF | |
| SCHEMBL15498098 | 0.90 | KIT (0.82) | KITABL1FGFR1KDRCSF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3246327-B1 | 3-ACETYLENYL-PYRAZOLE-PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USES THEREOF | SI CHUAN UNIV (CN) | 2022-11-23 | — | — | EP | disclosed |
| CN-111484482-B | Alkynyl pyrimidine or alkynyl pyridine compound, and composition and application thereof | 北京赛特明强医药科技有限公司 | 2022-06-21 | — | — | CN | disclosed |